Histopathological screening for prostate carcinoma: Is a benign biopsy a negative biopsy? - Abstract

In case of clinical suspicion of a prostate malignancy, a prostate biopsy is the most widely used approach to confirm prostate cancer.

Unfortunately, exclusion of prostate cancer is not feasible by means of biopsy and also the negative rate remains consistently high. Here, we review the information the surgical pathologist can still gain from a prostate biopsy in absence of overt carcinoma.

Written by:
Sailer V, Kristiansen G.   Are you the author?
Institute of Pathology, University Hospital of Bonn, Bonn, Germany.

Reference: APMIS. 2014 Aug;122(8):690-8.
doi: 10.1111/apm.12291


PubMed Abstract
PMID: 25046199

UroToday.com Prostate Cancer Section

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe